Key facts
- Senté’s last known valuation is $56.5M (Jun 2018).
- It has raised $38.6M; the latest was Later Stage VC in Apr 2026.
- Notable investors include ALMA Life Sciences.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Senté
- ·The full record, as it builds
Funding rounds
No funding rounds for Senté are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Senté
Developer of skin care products designed to deliver novel, science-based beauty goods. The company's products offer a formulation of active ingredients that help in cell renewal, new collagen development, skin hydration and gradually lightening the appearance of pigmented lesions, enabling customers to achieve younger-looking and healthier skin.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Carlsbad, CA, United States
- Founded
- 2007
- Employees
- 45
- Website
- sentelabs.com/
- Ownership
- Privately Held (backing)
Senté doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Senté shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Senté in its N-PORT filings yet. We sweep new filings monthly.